source
- Sanofi gains FDA clearance for Gaucher disease pillThe approval culminates a winding development journey for Infilbray, and provides Sanofi with a new source of income ahead of Dupixent’s looming patent expiration.BioPharma Dive · 45m ago↗ source
- STAT+: Lawmakers want U.S. biotech to outcompete ChinaLawmakers leading the congressional BIOTech Caucus say Washington needs to act in the sector — and fast:STAT · 57m ago↗ source
- STAT+: Epic defends competitive practices; promises AI access to recordsIn this edition of STAT Health Tech: EHR giant, Epic defends its competitive tactics, new data on AI and health care costs, and HLTH news.STAT · 3h ago↗ source